BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22736142)

  • 1. c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells.
    Hayashi K; Jutabha P; Endou H; Anzai N
    Oncol Rep; 2012 Sep; 28(3):862-6. PubMed ID: 22736142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
    Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
    Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
    Fan X; Ross DD; Arakawa H; Ganapathy V; Tamai I; Nakanishi T
    Biochem Pharmacol; 2010 Sep; 80(6):811-8. PubMed ID: 20510678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells.
    Kim CH; Park KJ; Park JR; Kanai Y; Endou H; Park JC; Kim DK
    Anticancer Res; 2006; 26(4B):2943-8. PubMed ID: 16886618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
    Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
    Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy.
    Ohkawa M; Ohno Y; Masuko K; Takeuchi A; Suda K; Kubo A; Kawahara R; Okazaki S; Tanaka T; Saya H; Seki M; Enomoto T; Yagi H; Hashimoto Y; Masuko T
    Biochem Biophys Res Commun; 2011 Mar; 406(4):649-55. PubMed ID: 21371427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model.
    Fukumoto S; Hanazono K; Fu DR; Endo Y; Kadosawa T; Iwano H; Uchide T
    Biochem Biophys Res Commun; 2013 Sep; 439(1):103-8. PubMed ID: 23954667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Shimizu K; Tominaga H; Yanagitani N; Sunaga N; Ishizuka T; Nagamori S; Promchan K; Nakajima T; Yamamoto N; Mori M; Kanai Y
    Anticancer Res; 2010 Dec; 30(12):4819-28. PubMed ID: 21187458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells.
    Kim DK; Kim IJ; Hwang S; Kook JH; Lee MC; Shin BA; Bae CS; Yoon JH; Ahn SG; Kim SA; Kanai Y; Endou H; Kim JK
    Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
    Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
    Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-type amino acid transporter 1 (LAT1): a new therapeutic target for canine mammary gland tumour.
    Fukumoto S; Hanazono K; Komatsu T; Ueno H; Kadosawa T; Iwano H; Uchide T
    Vet J; 2013 Oct; 198(1):164-9. PubMed ID: 23896327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAT1 regulates growth of uterine leiomyoma smooth muscle cells.
    Xia Luo ; Coon JS; Su E; Pearson EK; Ping Yin ; Ishikawa H; Bulun SE
    Reprod Sci; 2010 Sep; 17(9):791-7. PubMed ID: 20601542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
    Xiong J; Du Q; Liang Z
    Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: role in cell growth.
    Liu XM; Reyna SV; Ensenat D; Peyton KJ; Wang H; Schafer AI; Durante W
    FASEB J; 2004 Apr; 18(6):768-70. PubMed ID: 14977877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
    Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
    Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
    Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines.
    Fukumoto A; Tomoda K; Yoneda-Kato N; Nakajima Y; Kato JY
    FEBS Lett; 2006 Oct; 580(25):5836-44. PubMed ID: 17027978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.